Free Trial
Your Rate Never Goes Up! Save $100 a Year on MarketBeat All Access
Upgrade Now
Claim MarketBeat All Access Sale Promotion
Yastin Suneja

Yastin Suneja Analyst Performance

Senior Managing Director, Biotechnology Research Analyst at Guggenheim

Yastin Suneja is a stock analyst at Guggenheim focused in the healthcare sector, covering 46 publicly traded companies. Over the past year, Yastin Suneja has issued 93 stock ratings, including strong buy, buy, and hold recommendations. While full access to Yastin Suneja's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Yastin Suneja's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
150 Last 7 Years
Buy Recommendations
90.67% 136 Buy Ratings
Companies Covered
46 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.7%1 ratings
Buy90.0%135 ratings
Hold9.3%14 ratings
Sell0.0%0 ratings

Out of 150 total stock ratings issued by Yastin Suneja at Guggenheim, the majority (90.0%) have been Buy recommendations, followed by 9.3% Hold and 0.7% Strong Buy.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
46 companies

Yastin Suneja, an analyst at Guggenheim, currently covers 46 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
44 companies
95.7%
Miscellaneous
2 companies
4.3%

Yastin Suneja of Guggenheim specializes in stock coverage within the Healthcare sector, with additional focus on companies.

Coverage Industries

IndustryPercentage
BIOTECHNOLOGY
36 companies
78.3%
PHARMACEUTICALS
8 companies
17.4%
Miscellaneous
2 companies
4.3%

About Yastin Suneja

Mr. Suneja is a Senior Managing Director and Equity Research Analyst covering the Biotechnology sector, with over 16 years of experience in equity research. Since joining Guggenheim in 2018, he has provided in-depth analysis and investment insights on biotechnology companies, with a particular focus on those in the immunology, neurology, and inflammatory (INI) space. Previously, he was a Managing Director at SunTrust Robinson Humphrey and a Vice President at Cowen & Company, both specializing in biotechnology equity research. He began his career in Corporate Banking at Bank of America. Mr. Suneja holds an M.B.A. from Syracuse University and a B.Com from PGDAV College, University of Delhi.
Follow on LinkedIn

Yastin Suneja's Ratings History at Guggenheim

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
0 Results
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Avalo Therapeutics, Inc. stock logo
AVTX
Avalo Therapeutics
10/23/2026Reiterated Rating$7.45Neutral
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
10/20/2026Reiterated Rating$87.49$175.00Buy
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
10/19/2026Downgrade$0.42Neutral
Zenas BioPharma, Inc. stock logo
ZBIO
Zenas BioPharma
9/30/2026Reiterated Rating$26.76$55.00Buy
Cyclerion Therapeutics, Inc. stock logo
KRSA
Cyclerion Therapeutics
9/28/2026Initiated Coverage$31.00$70.00Buy
TRAX
First Tracks Biotherapeutics
9/16/2026Initiated Coverage$38.47$100.00Buy
TRAX
First Tracks Biotherapeutics
9/16/2026Initiated Coverage$38.47$100.00Buy
TRAX
First Tracks Biotherapeutics
9/16/2026Initiated Coverage$39.00$100.00Buy
Roivant Sciences Ltd. stock logo
ROIV
Roivant Sciences
9/9/2026Boost Price Target$41.48$46.00Buy
Alumis Inc. stock logo
ALMS
Alumis
9/3/2026Downgrade$10.35Neutral
Latigo Biotherapeutics, Inc. stock logo
LTGO
Latigo Biotherapeutics
9/1/2026Initiated Coverage$22.02$50.00Buy
Latigo Biotherapeutics, Inc. stock logo
LTGO
Latigo Biotherapeutics
9/1/2026Initiated Coverage$22.26$50.00Buy
Zenas BioPharma, Inc. stock logo
ZBIO
Zenas BioPharma
8/14/2026Reiterated Rating$29.04$55.00Buy
Zura Bio Limited stock logo
ZURA
Zura Bio
8/12/2026Boost Price Target$5.56$20.00Buy
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
8/11/2026Boost Price Target$220.89$275.00Buy
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
8/11/2026Reiterated Rating$103.25$200.00Buy
Sionna Therapeutics, Inc. stock logo
SION
Sionna Therapeutics
8/10/2026Downgrade$4.46Neutral
Avalo Therapeutics, Inc. stock logo
AVTX
Avalo Therapeutics
8/7/2026Set Price Target$18.70$48.00Buy
Sionna Therapeutics, Inc. stock logo
SION
Sionna Therapeutics
8/7/2026Boost Price Target$49.61$60.00Buy
Roivant Sciences Ltd. stock logo
ROIV
Roivant Sciences
8/7/2026Boost Price Target$36.09$42.00Buy
Adicet Bio, Inc. stock logo
ACET
Adicet Bio
8/6/2026Reiterated Rating$9.11$90.00Buy
Spyre Therapeutics, Inc. stock logo
SYRE
Spyre Therapeutics
8/5/2026Boost Price Target$106.85$130.00Buy
Stoke Therapeutics, Inc. stock logo
STOK
Stoke Therapeutics
8/4/2026Reiterated Rating$30.07$60.00Buy
argenex SE stock logo
ARGX
argenex
8/4/2026Initiated Coverage$844.27$1,185.00Buy
Phathom Pharmaceuticals, Inc. stock logo
PHAT
Phathom Pharmaceuticals
7/31/2026Lower Price Target$8.92$22.00Buy
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
7/31/2026Boost Price Target$165.52$222.00Buy
argenex SE stock logo
ARGX
argenex
7/24/2026Boost Price Target$924.08$1,185.00Buy
Biogen Inc. stock logo
BIIB
Biogen
7/21/2026Boost Price Target$202.12$280.00Buy
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
7/20/2026Boost Price Target$35.35$100.00Buy
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
6/24/2026Reiterated Rating$14.55$68.00Buy
Climb Bio, Inc. stock logo
CLYM
Climb Bio
6/8/2026Initiated Coverage$10.55$35.00Buy
Climb Bio, Inc. stock logo
CLYM
Climb Bio
6/8/2026Initiated Coverage$10.77$35.00Buy
Oculis Holding AG stock logo
OCS
Oculis
6/1/2026Lower Price Target$22.70$45.00Buy
Roivant Sciences Ltd. stock logo
ROIV
Roivant Sciences
5/26/2026Boost Price Target$29.96$36.00Buy
Immunovant, Inc. stock logo
IMVT
Immunovant
5/26/2026Boost Price Target$34.15$62.00Buy
Oculis Holding AG stock logo
OCS
Oculis
5/20/2026Initiated Coverage$27.91$75.00Buy
Oculis Holding AG stock logo
OCS
Oculis
5/20/2026Upgrade$31.00Strong-Buy
Alumis Inc. stock logo
ALMS
Alumis
5/15/2026Boost Price Target$24.63$34.00Buy
argenex SE stock logo
ARGX
argenex
5/8/2026Boost Price Target$787.31$1,135.00Buy
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
5/6/2026Reiterated Rating$144.75$175.00Buy
The $100 Stock Behind Elon's Next Move (Ad)

A small, publicly traded supplier trading under $100 a share has reportedly worked alongside Elon Musk for more than a decade. A federal filing may outline Musk's next major move: an AI network of up to a million satellites powered by the sun. James Altucher says this supplier holds the piece Musk doesn't own.tc pixel

Watch James Altucher's free Masterclass on this Musk-linked supplier stock
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
5/4/2026Boost Price Target$227.50$260.00Buy
DBV Technologies S.A. stock logo
DBVT
DBV Technologies
5/4/2026Reiterated Rating$19.10$51.00Buy
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
5/1/2026Boost Price Target$704.44$995.00Buy
Biogen Inc. stock logo
BIIB
Biogen
4/30/2026Boost Price Target$194.38$260.00Buy
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
4/27/2026Set Price Target$80.91$200.00Buy
InflaRx N.V. stock logo
IFRX
InflaRx
4/21/2026Reiterated Rating$1.63$14.00Buy
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
4/13/2026Reiterated Rating$61.89$125.00Buy
Neumora Therapeutics, Inc. stock logo
NMRA
Neumora Therapeutics
3/31/2026Reiterated Rating$1.93$14.00Buy
DBV Technologies S.A. stock logo
DBVT
DBV Technologies
3/27/2026Reiterated Rating$20.21$51.00Buy
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
3/25/2026Boost Price Target$158.75$245.00Buy
Immunic, Inc. stock logo
IMUX
Immunic
3/24/2026Initiated Coverage$11.70$70.00Buy
Cabaletta Bio, Inc. stock logo
CABA
Cabaletta Bio
3/24/2026Boost Price Target$2.70$16.00Buy
InflaRx N.V. stock logo
IFRX
InflaRx
3/20/2026Lower Price Target$0.91$14.00Buy
Zenas BioPharma, Inc. stock logo
ZBIO
Zenas BioPharma
3/16/2026Boost Price Target$23.23$55.00Buy
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
3/13/2026Reiterated Rating$31.99$60.00Buy
Adicet Bio, Inc. stock logo
ACET
Adicet Bio
3/13/2026Lower Price Target$7.04$100.00Buy
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
3/9/2026Reiterated Rating$62.63$90.00Buy
Sionna Therapeutics, Inc. stock logo
SION
Sionna Therapeutics
3/2/2026Boost Price Target$33.68$50.00Buy
argenex SE stock logo
ARGX
argenex
2/27/2026Lower Price Target$771.53$1,120.00Buy
Phathom Pharmaceuticals, Inc. stock logo
PHAT
Phathom Pharmaceuticals
2/27/2026Boost Price Target$12.94$25.00Buy
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
2/24/2026Boost Price Target$174.76$220.00Buy
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
2/10/2026Reiterated Rating$319.54$800.00Buy
Biogen Inc. stock logo
BIIB
Biogen
2/9/2026Boost Price Target$201.18$246.00Buy
Immunovant, Inc. stock logo
IMVT
Immunovant
2/9/2026Boost Price Target$27.05$44.00Buy
Roivant Sciences Ltd. stock logo
ROIV
Roivant Sciences
2/9/2026Boost Price Target$25.86$30.00Buy
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
2/9/2026Boost Price Target$784.43$975.00Buy
Stoke Therapeutics, Inc. stock logo
STOK
Stoke Therapeutics
2/5/2026Initiated Coverage$32.00$60.00Buy
Stoke Therapeutics, Inc. stock logo
STOK
Stoke Therapeutics
2/5/2026Initiated Coverage$32.40$60.00Buy
Avalo Therapeutics, Inc. stock logo
AVTX
Avalo Therapeutics
2/2/2026Initiated Coverage$15.11$50.00Buy
Rapt Therapeutics stock logo
RAPT
Rapt Therapeutics
1/20/2026Downgrade$57.52Neutral
Alumis Inc. stock logo
ALMS
Alumis
1/7/2026Boost Price Target$16.23$32.00Buy
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
1/2/2026Reiterated Rating$177.09$205.00Buy
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
12/29/2025Reiterated Rating$301.40Buy
SAB Biotherapeutics, Inc. stock logo
SABS
SAB Biotherapeutics
12/19/2025Initiated Coverage$3.95$15.00Buy
SAB Biotherapeutics, Inc. stock logo
SABS
SAB Biotherapeutics
12/19/2025Initiated Coverage$3.84$15.00Buy
Roivant Sciences Ltd. stock logo
ROIV
Roivant Sciences
12/18/2025Reiterated Rating$22.70$28.00Buy
Immunovant, Inc. stock logo
IMVT
Immunovant
12/18/2025Reiterated Rating$26.98$41.00Buy
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
12/18/2025Reiterated Rating$45.60Buy
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
12/18/2025Reiterated Rating$110.82$175.00Buy
DBV Technologies S.A. stock logo
DBVT
DBV Technologies
12/17/2025Reiterated Rating$17.98$51.00Buy
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
12/9/2025Reiterated Rating$270.98$760.00Buy
DBV Technologies S.A. stock logo
DBVT
DBV Technologies
12/3/2025Initiated Coverage$12.90$35.00Buy
DBV Technologies S.A. stock logo
DBVT
DBV Technologies
12/3/2025Initiated Coverage$12.99$35.00Buy
Roivant Sciences Ltd. stock logo
ROIV
Roivant Sciences
11/14/2025Reiterated Rating$20.56$25.00Buy
InflaRx N.V. stock logo
IFRX
InflaRx
11/10/2025Boost Price Target$1.23$22.00Buy
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
11/6/2025Reiterated Rating$172.35$540.00Buy
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
11/5/2025Boost Price Target$36.13$100.00Buy
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
11/4/2025Boost Price Target$134.39$205.00Buy
Phathom Pharmaceuticals, Inc. stock logo
PHAT
Phathom Pharmaceuticals
10/30/2025Reiterated Rating$13.31$20.00Buy
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
10/29/2025Boost Price Target$654.48$865.00Buy
Cigar Lake Flooded Again Uranium Supply Shock Repeats (Ad)

In 2006, a flooded mine at Cigar Lake sent uranium prices from the 50 range to 136 in eight months. This past May, flooding hit the same complex again, and in July Cigar Lake went down a second time, disrupting the world's largest high-grade uranium mine. Gerardo Del Real calls this the Third Convergence Event and has backed three small companies positioned in front of it.tc pixel

See the three companies positioned for uranium's next supply shock
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
10/27/2025Initiated Coverage$27.25$60.00Buy
Rapt Therapeutics stock logo
RAPT
Rapt Therapeutics
10/27/2025Initiated Coverage$29.53$70.00Buy
Neumora Therapeutics, Inc. stock logo
NMRA
Neumora Therapeutics
10/27/2025Upgrade$2.63$14.00Buy
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
10/16/2025Set Price Target$189.69$350.00Buy
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
10/10/2025Boost Price Target$90.61$150.00Buy
Adicet Bio, Inc. stock logo
ACET
Adicet Bio
10/8/2025Boost Price Target$13.65$128.00Buy
MoonLake Immunotherapeutics stock logo
MLTX
MoonLake Immunotherapeutics
9/30/2025Lower Price Target$6.24$20.00Buy
Adicet Bio, Inc. stock logo
ACET
Adicet Bio
9/19/2025Reiterated Rating$12.97$112.00Buy
argenex SE stock logo
ARGX
argenex
9/18/2025Reiterated Rating$734.77$1,070.00Buy
Roivant Sciences Ltd. stock logo
ROIV
Roivant Sciences
9/18/2025Boost Price Target$15.42$21.00Buy
Tourmaline Bio, Inc. stock logo
TRML
Tourmaline Bio
9/10/2025Reiterated Rating$47.64$48.00Neutral
Tourmaline Bio, Inc. stock logo
TRML
Tourmaline Bio
9/9/2025Downgrade$47.64Hold
Dianthus Therapeutics, Inc. stock logo
DNTH
Dianthus Therapeutics
9/9/2025Boost Price Target$31.80$100.00Buy
Forte Biosciences, Inc. stock logo
FBRX
Forte Biosciences
8/18/2025Initiated Coverage$11.57$75.00Buy
Forte Biosciences, Inc. stock logo
FBRX
Forte Biosciences
8/18/2025Initiated Coverage$11.49$75.00Buy
Tourmaline Bio, Inc. stock logo
TRML
Tourmaline Bio
8/14/2025Reiterated Rating$21.88$55.00Buy
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
8/1/2025Boost Price Target$545.46$815.00Buy
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
8/1/2025Boost Price Target$126.03$175.00Buy
argenex SE stock logo
ARGX
argenex
8/1/2025Boost Price Target$667.75$1,070.00Buy
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
7/23/2025Boost Price Target$10.00$101.00Buy
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
6/24/2025Reiterated Rating$2.42$26.00Buy
Alumis Inc. stock logo
ALMS
Alumis
6/10/2025Upgrade$3.43$18.00Buy
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
5/28/2025Reiterated Rating$21.95$90.00Buy
Cabaletta Bio, Inc. stock logo
CABA
Cabaletta Bio
5/15/2025Boost Price Target$1.70$25.00Buy
argenex SE stock logo
ARGX
argenex
5/9/2025Lower Price Target$547.89$1,065.00Buy
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
5/6/2025Boost Price Target$20.97$54.00Buy
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
5/6/2025Boost Price Target$125.03$165.00Buy
Phathom Pharmaceuticals, Inc. stock logo
PHAT
Phathom Pharmaceuticals
5/2/2025Lower Price Target$2.76$12.00Buy
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
5/1/2025Lower Price Target$589.21$810.00Buy
Phathom Pharmaceuticals, Inc. stock logo
PHAT
Phathom Pharmaceuticals
4/2/2025Reiterated Rating$5.98Buy
Cabaletta Bio, Inc. stock logo
CABA
Cabaletta Bio
4/1/2025Reiterated Rating$1.32$23.00Buy
Zura Bio Limited stock logo
ZURA
Zura Bio
3/26/2025Reiterated Rating$1.37$15.00Buy
InflaRx N.V. stock logo
IFRX
InflaRx
3/26/2025Boost Price Target$1.33$10.00Buy
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
3/25/2025Reiterated Rating$2.29$26.00Buy
Immunovant, Inc. stock logo
IMVT
Immunovant
3/20/2025Reiterated Rating$18.84Buy
Dianthus Therapeutics, Inc. stock logo
DNTH
Dianthus Therapeutics
3/12/2025Reiterated Rating$23.06$84.00Buy
Zenas BioPharma, Inc. stock logo
ZBIO
Zenas BioPharma
3/12/2025Reiterated Rating$8.43$45.00Buy
argenex SE stock logo
ARGX
argenex
3/10/2025Boost Price Target$575.37$1,100.00Buy
Immunovant, Inc. stock logo
IMVT
Immunovant
3/10/2025Reiterated Rating$20.28Buy
Neumora Therapeutics, Inc. stock logo
NMRA
Neumora Therapeutics
3/7/2025Downgrade$1.52Neutral
Sionna Therapeutics, Inc. stock logo
SION
Sionna Therapeutics
3/4/2025Initiated Coverage$14.41$45.00Buy
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
2/10/2025Lower Price Target$122.62$163.00Buy
Immunovant, Inc. stock logo
IMVT
Immunovant
2/10/2025Lower Price Target$20.41$44.00Buy
ACADIA Pharmaceuticals Inc. stock logo
ACAD
ACADIA Pharmaceuticals
1/3/2025Downgrade$18.66$20.00Neutral
Surrozen, Inc. stock logo
SRZN
Surrozen
1/3/2025Upgrade$14.25$45.00Buy
Q32 Bio Inc. stock logo
QTTB
Q32 Bio
12/11/2024Downgrade$7.90Neutral